Some people are discovering that being thinner can sometimes mean looking older. Local cosmetic surgeons weigh-in with ...

Novo Nordisk sees 65% obesity drug sales growth, forecasts $8.14–$9.59B FY25 free cash flow. Click here to read an analysis ...

Whether the headlines cite Ozempic or obesity, Western media remains fixated on weight. But in East Asia, the conversation ...

Eight weeks. That’s how long it takes, on average, for the pounds to begin creeping back after someone stops taking the world ...

Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...

GLP-1 drugs like Ozempic and Mounjaro helped men with low testosterone raise their levels without hormone replacement in a ...

In a culture where thinness is still the price of admission, choice becomes murky. Representation becomes hollow when those who once stood outside the norm quietly conform – not necessarily because ...

Stimulant Metabolic SupportChicago, July 19, 2025 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes ...

After Falling 68%, Where Will This Weight-Loss Drug Stock Be in 2 Years? History Shows Massive Gains Ahead. Yet another ...

Modern weight loss medications represent a breakthrough, but they are most effective when combined with the right lifestyle strategies. Here's what that looks like.

People who took semaglutide over a slower, more flexible schedule were significantly less likely to experience nausea and to ...

New and disturbing concerns about fake GLP-1 drugs are cited in a letter sent to the FDA by Tennessee officials, including Sen. Marsha Blackburn.